🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

Recruitingn/aAges 18 Years - anyAllUniversity of California, San Diego
NCT07518784 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. This is the second phase of a project in which we are testing a new technology to evaluate the liver (LiverScope®). We will compare LiverScope® to other methods to evaluate the liver, including advanced conventional liver MR exams. MR exams are common exams used to monitor MASLD (also known as NAFLD). Conventional MR scanners use magnetic fields and radio waves to make pictures of the liver. LiverScope® is a small, portable MR-based device that uses similar, but simplified technology, and can be used on top of an exam table in an outpatient setting. LiverScope® currently is not approved for clinical use. In this second phase of the study, we took what we learned in the first phase to optimize the LiverScope® device and are now testing to see how LiverScope® measurements com

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * Known or clinically suspected MASLD * BMI greater than 27 kg/m\^2 and less than 45 kg/m\^2 at the time of referral * Ability to lie on LiverScope® device table for about 60 minutes * Ability to hold breath repeatedly for about 20 seconds during MR and LiverScope® exams * Willing and able to undergo all study procedures Exclusion Criteria: * UCSD study personnel or Livivos study personne * Contraindications to MR * Potential participant states that she knows that she is pregnant, thinks she may be pregnant, or states that she is trying to become pregnant. * Known chronic liver disease other than MASLD
💊

What it tests

  • LiverScope® exam
  • MR exam
  • Blood draw
  • Body measurements
  • Questionnaire
📍

Where

1 site
University of California San Diego
La Jolla, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy